Topics

Commercial manufacture of Bluebird’s gene therapy begins, launched in Germany

04:14 EST 16 Jan 2020 | BioPharma-Reporter

Apceth announces that it has started the commercial manufacture of Zyntelgo, after health insurance companies in Germany agree to pricing structure.

Original Article: Commercial manufacture of Bluebird’s gene therapy begins, launched in Germany

NEXT ARTICLE

More From BioPortfolio on "Commercial manufacture of Bluebird’s gene therapy begins, launched in Germany"

Quick Search